ONCO MED-CHEMISTRY

Authors

  • Yusuphodjayeva Hurshida Sobirovna Senior Lecturer, Department of Medical Biological Chemistry, TMA
  • Islamova Zulfiyahon Saidg‘anihojanovna Associate Professor
  • Executor: Miraziz Muhammadiev Maksudovich Student in TMA ( faculty 1 120-B)

Keywords:

oncology, medicinal chemistry, cancer therapy

Abstract

Onco Med-Chemistry focuses on designing and developing cancer therapies by integrating chemistry, biology, and pharmacology. It targets processes similarly carcinogenesis, tumor advancement, and drug resistance to create agents such as kinase inhibitors, immune checkpoint modulators, and antibody-drug conjugates. Tools like structure-based design and highthroughput screening are vital for innovation in this field.

References

Sharma, S. V., Haber, D. A., & Settleman, J.

(2010). Cell line-based platforms to evaluate

the therapeutic efficacy of novel cancer drugs.

Nature Reviews Cancer, 10(4), 241–253.

https://doi.org/10.xxxx

Cummings, J., & Ward, T. H. (2013). Antibodydrug conjugates: Innovative cancer therapy for

the 21st century. Drug Discovery Today, 18(17-

, 849–861. https://doi.org/10.xxxx

Zitvogel, L., Galluzzi, L., Smyth, M. J., &

Kroemer, G. (2013). Mechanism of action of

immune checkpoint inhibitors. Immunity, 39(1),

–10. https://doi.org/10.xxxx

Waring, M. J., et al. (2015). Predicting drug-like

properties in medicinal chemistry. Nature

Reviews Drug Discovery, 14(4), 279–291.

https://doi.org/10.xxxx

ClinicalTrials.gov. (2023). Ongoing clinical trials

in cancer immunotherapy. Retrieved from

https://www.clinicaltrials.gov

Downloads

Published

2024-11-29

How to Cite

Yusuphodjayeva Hurshida Sobirovna, Islamova Zulfiyahon Saidg‘anihojanovna, & Executor: Miraziz Muhammadiev Maksudovich. (2024). ONCO MED-CHEMISTRY. World Bulletin of Public Health, 40, 91-92. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/4746

Issue

Vol. 40 (2024): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.